Cargando…
Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report
BACKGROUND: The use of isavuconazole is approved for the management of invasive aspergillosis and mucormycosis, only in adults, as no paediatric pharmacology studies have been reported to date. Very few paediatric cases have been published concerning the use of isavuconazole. Amphotericin B is the o...
Autores principales: | Cornu, Marjorie, Bruno, Bénédicte, Loridant, Séverine, Navarin, Pauline, François, Nadine, Lanternier, Fanny, Amzallag-Bellenger, Elisa, Dubos, François, Mazingue, Françoise, Sendid, Boualem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282241/ https://www.ncbi.nlm.nih.gov/pubmed/30522521 http://dx.doi.org/10.1186/s40360-018-0273-7 |
Ejemplares similares
-
Disease Entities in Mucormycosis
por: Serris, Alexandra, et al.
Publicado: (2019) -
Isavuconazole as salvage therapy for mucormycosis
por: Graves, Bianca, et al.
Publicado: (2016) -
Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole
por: Ilharco, Marta, et al.
Publicado: (2019) -
Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections
por: Mery, Alexandre, et al.
Publicado: (2016) -
Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
por: Donnelley, Monica A, et al.
Publicado: (2016)